DNAH8 and neoplasm: Furthermore, ATPase activity assays revealed a notable reduction in cell viability upon YZ-836P treatment, with PDO #33 showing a higher IC50 compared to PDO #32, a discrepancy potentially rooted in the original tumor’s greater malignancy in PDO #33 (Fig. 6B-C).